Yao-Ching Hung

No ORCID on file · 5 papers in corpus
other 2026
Platinum sensitivity drives prognosis in endometriosis-associated ovarian carcinoma compared with high-grade serous ovarian carcinoma: Insights from a 10-year retrospective study
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2025.11.029

OBJECTIVE: To compare clinical features, treatment responses, and survival outcomes between endometriosis-associated ovarian cancer (EAOC) and high-grade serous ovarian carcinoma (HGSOC), with a focus on platinum resistance. MATERIALS AND …

other 2022
Predicting Long-Term Prognoses and Grading Platinum Sensitivity Using a Novel Progression-Free Interval Criterion in Ovarian Clear Cell Carcinoma: A Multi-Institutional Cohort Study
Cancers ·doi:10.3390/cancers14071746

This large-scale study aimed to determine the long-term influences of potential prognostic predictors and progression-free interval (PFI) criteria for grading platinum-sensitivity in ovarian clear cell carcinoma (OCCC). We retrospectively r…

article 2004
Vascular endothelial growth factor A and C gene expression in endometriosis
Human pathology ·doi:10.1016/j.humpath.2004.07.020

Angiogenesis is essential for the pathogenesis of endometriosis. Gene expression levels of vascular endothelial growth factor (VEGF) A and C in 10 eutopic endometrial, 23 normal peritoneal, and 62 endometriotic tissues surgically obtained f…

article 2002
Influence of severe endometriosis on gene expression of vascular endothelial growth factor and interleukin-6 in granulosa cells from patients undergoing controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer
Fertility and sterility ·doi:10.1016/s0015-0282(02)03339-3

ObjectiveTo evaluate how endometriosis affects expression of vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) in granulosa cells.DesignProspective study.SettingIVF-ET program at Osaka Medical College.Patient(s)Seventeen pa…

article 2002
Survivin Gene Expression in Endometriosis
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.87.7.8682

Survivin is a novel inhibitor of apoptosis and is expressed during fetal development and in cancer tissues, but its expression has not been reported in normal adult tissues or benign diseases. We investigated survivin gene and protein expre…